BOSTON — In a large registry analysis, transcatheter edge-to-edge mitral valve repair had a high rate of device success in patients with severe mitral regurgitation and cardiogenic shock.In addition, compared with device failure, device success with the mitral valve repair system (MitraClip, Abbott) was associated with reduced risk for all-cause mortality at 1 year.